Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease

Diabetic kidney disease (DKD) is a leading cause of end-stage renal disease worldwide and the major cause of renal failure among patients on hemodialysis. Numerous studies have demonstrated that transient activation of epidermal growth factor receptor (EGFR) pathway is required for promoting kidney...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Lili, Bayliss, George, Zhuang, Shougang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870700/
https://www.ncbi.nlm.nih.gov/pubmed/33574751
http://dx.doi.org/10.3389/fphar.2020.598910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870700/
https://www.ncbi.nlm.nih.gov/pubmed/33574751
http://dx.doi.org/10.3389/fphar.2020.598910

Ejemplares similares